SVRA (STOCKS)
Savara Inc.
$6.030000
+0.370000 (+6.54%)
Prev close: $5.660000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Matthew Pauls
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $1,209.53M
- Employees
- 59
- P/E (TTM)
- -11.08
- P/B (TTM)
- 5.70
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $0.00 |
| Operating Expenses | $123.55M |
| Depreciation and Amortization | $87.00K |
| Other Operating Expenses | $123.46M |
| Operating Income/Loss | -$123.55M |
| Income/Loss From Continuing Operations After Tax | -$118.84M |
| Income/Loss From Continuing Operations Before Tax | -$118.84M |
| Income Tax Expense/Benefit | $0.00 |
| Income Tax Expense/Benefit, Current | $0.00 |
| Net Income/Loss | -$118.84M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$118.84M |
| Net Income/Loss Available To Common Stockholders, Basic | -$118.84M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.53 |
| Diluted Earnings Per Share | -$0.53 |
| Basic Average Shares | 222,387,531 |
| Diluted Average Shares | 222,387,531 |
| Assets | $253.44M |
| Current Assets | $241.62M |
| Noncurrent Assets | $11.82M |
| Fixed Assets | $100.00K |
| Other Non-current Assets | $11.72M |
| Liabilities | $50.30M |
| Current Liabilities | $20.40M |
| Accounts Payable | $5.76M |
| Wages | $6.55M |
| Other Current Liabilities | $8.09M |
| Noncurrent Liabilities | $29.91M |
| Long-term Debt | $29.91M |
| Equity | -$87.00K |
| Equity Attributable To Noncontrolling Interest | -$203.22M |
| Equity Attributable To Parent | $203.13M |
| Liabilities And Equity | $253.44M |
| Net Cash Flow From Operating Activities | -$101.04M |
| Net Cash Flow From Operating Activities, Continuing | -$101.04M |
| Net Cash Flow From Investing Activities | -$18.44M |
| Net Cash Flow From Investing Activities, Continuing | -$18.44M |
| Net Cash Flow From Financing Activities | $137.81M |
| Net Cash Flow From Financing Activities, Continuing | $137.81M |
| Net Cash Flow | $18.33M |
| Net Cash Flow, Continuing | $18.33M |
| Comprehensive Income/Loss | -$118.17M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$118.17M |
| Other Comprehensive Income/Loss | $663.00K |
| Other Comprehensive Income/Loss Attributable To Parent | $663.00K |